BR112021017993A2 - Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos - Google Patents

Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos

Info

Publication number
BR112021017993A2
BR112021017993A2 BR112021017993A BR112021017993A BR112021017993A2 BR 112021017993 A2 BR112021017993 A2 BR 112021017993A2 BR 112021017993 A BR112021017993 A BR 112021017993A BR 112021017993 A BR112021017993 A BR 112021017993A BR 112021017993 A2 BR112021017993 A2 BR 112021017993A2
Authority
BR
Brazil
Prior art keywords
capsule
methods
lumen
therapeutic agent
drug delivery
Prior art date
Application number
BR112021017993A
Other languages
English (en)
Portuguese (pt)
Inventor
Lynn Toledo April
Arvinder Dhalla
Baber Syed
Joel Harris
Kyle Horlen
Mir Hashim
Mir Imran
Padma Karamchedu
Radhika Korupolu
Rodolphe Ruffy
Simret Beraki
Original Assignee
Rani Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rani Therapeutics Llc filed Critical Rani Therapeutics Llc
Publication of BR112021017993A2 publication Critical patent/BR112021017993A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
BR112021017993A 2019-03-13 2020-03-12 Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos BR112021017993A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962818053P 2019-03-13 2019-03-13
US201962820174P 2019-03-18 2019-03-18
PCT/US2020/022496 WO2020186121A1 (en) 2019-03-13 2020-03-12 Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Publications (1)

Publication Number Publication Date
BR112021017993A2 true BR112021017993A2 (pt) 2022-01-18

Family

ID=72424820

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021017993A BR112021017993A2 (pt) 2019-03-13 2020-03-12 Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos

Country Status (10)

Country Link
US (1) US20200289620A1 (cg-RX-API-DMAC7.html)
EP (1) EP3937971A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022524446A (cg-RX-API-DMAC7.html)
KR (1) KR20210138646A (cg-RX-API-DMAC7.html)
CN (1) CN113784724A (cg-RX-API-DMAC7.html)
AU (1) AU2020237517A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021017993A2 (cg-RX-API-DMAC7.html)
CA (1) CA3133086A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021011047A (cg-RX-API-DMAC7.html)
WO (1) WO2020186121A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8721620B2 (en) 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3706720B1 (en) * 2017-11-07 2026-07-01 Rani Therapeutics, LLC COAGULATION FACTOR PREPARATIONS FOR ADMINISTERING INTO INTESTINAL TRACT TISSUE BY MEANS OF AN ORGIVE-IN-SWALLOW MEDICATION DELIVERY DEVICE
CN112451500B (zh) * 2020-12-18 2022-05-17 南京鼓楼医院 一种磁响应载药微针机器人及其制备方法和应用
DK181267B1 (en) * 2021-10-28 2023-06-14 Biograil ApS Drug delivery device with capsule lock
WO2025081168A1 (en) * 2023-10-12 2025-04-17 The Brigham And Women's Hospital, Inc. An intra-abdominal injection system

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8721620B2 (en) * 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
US9402806B2 (en) * 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) * 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) * 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) * 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) * 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) * 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) * 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) * 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) * 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) * 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9415004B2 (en) * 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) * 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) * 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US10639272B2 (en) * 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US20230374155A1 (en) * 2014-05-15 2023-11-23 Rani Therapeutics, Llc Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2015176031A2 (en) * 2014-05-15 2015-11-19 Incube Labs, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
US10689460B2 (en) * 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US11548940B2 (en) * 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
AU2016257813B2 (en) * 2015-05-01 2021-05-13 Rani Therapeutics, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
WO2017004623A1 (en) * 2015-07-02 2017-01-05 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3706720B1 (en) * 2017-11-07 2026-07-01 Rani Therapeutics, LLC COAGULATION FACTOR PREPARATIONS FOR ADMINISTERING INTO INTESTINAL TRACT TISSUE BY MEANS OF AN ORGIVE-IN-SWALLOW MEDICATION DELIVERY DEVICE
US11473339B2 (en) * 2018-01-31 2022-10-18 Spectrum Brands, Inc. Field-handable gate latch
US20200206132A1 (en) * 2018-12-31 2020-07-02 Incube Labs, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
MX2021013310A (es) * 2019-05-03 2022-02-11 Rani Therapeutics Llc Preparaciones de factor de cogulación para la administración en el tejido del tracto intestinal usando un dispositivo de administración de medicamentos ingeribles.

Also Published As

Publication number Publication date
EP3937971A1 (en) 2022-01-19
JP2022524446A (ja) 2022-05-02
MX2021011047A (es) 2021-12-15
AU2020237517A1 (en) 2021-10-14
KR20210138646A (ko) 2021-11-19
EP3937971A4 (en) 2022-12-14
WO2020186121A1 (en) 2020-09-17
US20200289620A1 (en) 2020-09-17
CA3133086A1 (en) 2020-09-17
CN113784724A (zh) 2021-12-10
AU2020237517A2 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
MX2024005949A (es) Preparaciones de agente terapeutico para administracion en un lumen del tracto intestinal utilizando un dispositivo de administracion de farmaco tragable.
MX2021011047A (es) Preparaciones de agentes terapéuticos y métodos para la administración de fármacos en un lumen del tracto intestinal usando un dispositivo de administración de fármacos ingerible.
BR112021021904A2 (pt) Preparações de fator da coagulação para liberação em tecido do trato intestinal usando um dispositivo de liberação de fármacos ingerível
MX2022009523A (es) Formulaciones farmaceuticas.
BR112021017289A2 (pt) Distribuição propulsiva de fármacos a partir de um dispositivo engolível dentro do trato intestinal de um paciente
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2016172396A3 (en) Multi-chamber sequential delivery syringe
IN2014CN00338A (cg-RX-API-DMAC7.html)
WO2007109684A3 (en) Dose packaging system for load-dose titration administration of a liquid formulation
MX2021012050A (es) Formulaciones de proteinas liquidas que contienen agentes reductores de viscosidad.
EA201270795A1 (ru) Комплект трубок с вентилем улучшенной конструкции для подключения флаконов
BR112012019549A2 (en) reservoir for use in a medicament module, medicament module comprising that reservoir and drug delivery device.
BR112015022067A2 (pt) método e aparato para a administração de droga a um sítio alvo
BR112012033077B8 (pt) Composição farmacêutica para administração intravenosa, uso de uma composição farmacêutica, e, kit
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
MX2020004112A (es) Provision de un regimen de dosificacion de farmaco farmacocinetico.
MX378264B (es) Sistema para la entrega de polímeros líquidos para la administración prolongada de fármacos.
Binson et al. Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps
BR112016027435A2 (pt) formulação inovadora de meloxicam
EP4473987A4 (en) Device for administering a medicinal solution
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
BR112022003895A2 (pt) Sistema e método de entrega de múltiplos fármacos
WO2010034016A3 (en) Diaphragm drug pump
BR112018000018A2 (pt) dispositivo e sistema de liberação de uso único com aspectos de segurança
BR112012023396A2 (pt) Micelas de gangliosídeo como um sistema de entrega para drogas hidrofóbicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2870 DE 06-01-2026 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.